Caffeine reduces cerebral blood flow in patients recovering from an ischaemic stroke

Age and Ageing

Volumn 33, Issue 3, 2004, Pages 299-303

  Ragab, Suzanne ^a   Lunt, Michael ^b   Birch, Anthony ^c   Thomas, Peter ^a   Jenkinson, Damian F ^b  

^a POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Caffeine; Cerebral blood flow; Elderly; Ischaemic; Stroke; Transcranial Doppler

Indexed keywords

CAFFEINE; PLACEBO; XENON 133;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; BLOOD FLOWMETRY; BRAIN BLOOD FLOW; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIET RESTRICTION; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; MALE; MIDDLE CEREBRAL ARTERY; PRIORITY JOURNAL; RANDOMIZATION;

AGED; AGED, 80 AND OVER; BLOOD FLOW VELOCITY; BRAIN ISCHEMIA; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR CIRCULATION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; XENON RADIOISOTOPES;

EID: 2442497200     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/afh091     Document Type: Article

References (27)

1. Nehlig A, Daval J, Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Revs 1992; 17: 139-70.
2. Fredholm BB. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol Toxicol 1995; 76: 93-101.
3. Mathew RJ. Caffeine and cerebral blood flow. Br J Psychiatry 1983; 143: 604-8.
4. Mathew RJ. Caffeine induced changes in cerebral circulation. Stroke 1985; 16: 814-17.
5. Cameron OG, Modell JG, Hariharan M. Caffeine and human cerebral blood flow: a positron emission tomography study. Life Sci 1990; 47: 1141-46.
6. Hanrahan A, Lunt MJ, Kerr D, Jenkinson DF. Caffeine reduces cerebral blood velocity in patients recovering from acute ischaemic stroke. Cerebrovasc Dis 1999; 9 (Suppl 1): 94.
7. Jenkinson D, Hanrahan A, Lunt M, Kerr D. Effect of caffeine on middle cerebral artery blood velocity in patients recovering from acute ischaemic stroke. Lancet 1998; The Challenge of Stroke: 42-43 (abstract).
8. Jenkinson D, Hanrahan A, Lunt M, Kwan J, Kerr D. Caffeine reduces cerebral blood velocity in patients recovering from acute ischaemic stroke. Age Ageing 1999; 28 (Suppl 2): 51.
9. Prencipe M. Reproducibility of rCBF determinations (discussion). Eur Neurol 1972; 6: 234-5.
10. Blauenstein UR, Halsey JH, Wilson EM, Wills EL, Risberg J. 133 Xenon inhalation method. Analysis of reproducibility: some of its phyiological implications. Stroke 1977; 8: 92-102.
11. Bamford J, Sandercock P, Dennis M et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337: 1521-26.
12. Colin C, Wade DT, Davies S, Home V. The Barthel ADL index: a reliability study. Int Disabil Stud 1988; 10: 61-63.
13. Bunker ML, McWilliams M. Caffeine content of common beverages. J Am Dietetic Centre 1979: 74; 28-32.
14. Risberg J, Prohovnik I. rCBF measurements by 133-Xenon inhalation: recent methodological advances. Prog Nucl Med 1981; 7: 70-81.
15. 2 reactivity testing without blood pressure monitoring. Stroke 1999; 30: 398-401.
16. Nakane H, Ibayashi S, Fujii K et al. Cerebral blood flow and metabolism in patients with silent brain infarction: occult misery perfusion in the cerebral cortex. J Neurol Neurosurg Psychiatry 1988; 65: 317-21.
17. Nariai T, Senda M, Ishii K et al. Posthyperventilatory steal response in chronic cerebral haemodynamic stress. A positron emission tomography study. Stroke 1998; 29: 1281-92.
18. Geismar P, Marqardsen J, Sylvest J. Controlled trial of intravenous aminophylline in acute cerebral infarction. Acta Neurol Scand 1976; 54: 173-80.
19. Britton M, De Faire U, Helmers C, Miah K, Rane A. Lack of effect of theophylline on the outcome of cerebral infarction. Acta Neurol Scand 1980; 62: 116-23.
20. Mohiuddin AA, Bath FJ, Bath PMW. Theophylline, aminophylline, caffeine and analogues for acute stroke (Cochrane Review). The Cochrane Library, Issue 4, 2000. Oxford: Update Software, 2000.
21. Sutherland GR, Peeling J, Leisuk HJ et al. The effects of caffeine on ischaemic neuronal injury as determined by magnetic resonance imaging and histopathology. Neuroscience 1991; 42; 171-82.
22. Rudolphi KA, Schubert P, Parkinson FE, Fredholm BB. Adenosine and brain ischaemia. Cerebrovasc Brain Metabolism Rev 1992; 4: 346-69.
23. Rudolphi KA, Keil M, Fastbom J, Fredholm BB. Ischaemic damage in gerbil hippocampus is reduced following upregulation of adenosine (A1) receptors by caffeine treatment. Neurosci Letters 1989; 103: 274-80.
24. Wu PH, Phillis JW. Up-regulation of brain diazepam binding sites in chronic caffeine treated rats. Brain Res 1984; 294: 186-89.
25. Paul S, Kurunwune B, Biaggioni I. Caffeine withdrawal: apparent heterologous sensitization to adenosine and prostacyclin actions in human platelets. J Pharmacol Exp Therapeutics 1993; 267: 838-43.
26. Varani K, Portaluppi F, Merighi S et al. Caffeine alters A2a adenosine receptors and their function in human platelets. Circulation 1999; 99: 2499-502.
27. Biaggioni I, Paul S, Puckett A, Arzubiaga C. Caffeine and theophylline as adenosine receptor antagonists. J Pharmacol Exp Therapeutics 1991; 258: 588-93.